We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · November 23, 2021

AHA 2021: PREPARE-IT 2 Fails To Show Significant Benefit for Icosapent Ethyl in Nonhospitalized Patients With COVID-19

Study author notes, however, that trends are in right direction and a larger randomized trial is needed

PracticeUpdate Editorial Team


Further Reading